arrow
R

Raphaël Porcher

universite paris cite
H指数:92
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for Heart Failure with Reduced Ejection Fraction: NET-COST-HFrEF

射血分数降低的心力衰竭药物治疗的网络荟萃分析及成本效益评价:NET-COST-HFrEF

2026-07-160
OA
Impact of an intervention standardizing the perinatal management of extremely preterm infants on the child’s survival without severe morbidity: a stepped-wedge cluster-randomized trial (PREMEX study)

一项阶梯楔形整群随机试验(PREMEX研究):标准化极早产儿围产期管理干预措施对儿童无严重并发症生存率的影响

2026-05-060
OAAI
The Geographical Deprivation Index is Independently Associated With All-Cause Long-Term Mortality in Resectable Lung Cancer

地理剥夺指数与可切除肺癌患者的全因长期死亡率独立相关。

2025-11-010
PRE
Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients with ANCA-Associated Vasculitis

基线透析和血浆置换对ANCA相关性血管炎患者肾预后的影响

2025-09-040
OAAI
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study

糖皮质激素与糖皮质激素联合环磷酰胺在无不良预后因素的嗜酸性肉芽肿性多血管炎中的比较:一项目标试验模拟研究

2025-06-010
PRE
Food additive mixtures and type 2 diabetes incidence: Results from the NutriNet-Santé prospective cohort

食品添加剂混合物与2型糖尿病发病率:NutriNet-Santé前瞻性队列研究的结果

2025-04-080
OA
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study
CANCER
IF5.1
2024-12-080
PRE
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors

糖皮质激素与糖皮质激素联合环磷酰胺治疗嗜酸性肉芽肿性多血管炎预后不良因素

2024-12-010
PRE
When to stop immunotherapy for advanced melanoma: the emulated target trials

何时停止晚期黑色素瘤的免疫治疗: 模拟的目标试验

2024-12-010
PRE
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab plus nivolumab vs. nivolumab in a real-world setting

在真实世界环境中,ipilimumab 联合 nivolumab 与 nivolumab 单药治疗转移性黑色素瘤的一线疗效与安全性比较

2024-11-280
PRE